Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tigatuzumab (CS-1008), a humanized IgG1 monoclonal antibody, specifically targets death receptor 5 (DR5), inducing apoptosis in cancer cells and inhibiting tumor growth in vivo. It holds potential for cancer research applications [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry |
Description | Tigatuzumab (CS-1008), a humanized IgG1 monoclonal antibody, specifically targets death receptor 5 (DR5), inducing apoptosis in cancer cells and inhibiting tumor growth in vivo. It holds potential for cancer research applications [1]. |
Molecular Weight | 144.6 (kDa) |
CAS No. | 918127-53-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tigatuzumab 918127-53-4 inhibitor inhibit